Guided Detection of MRSA with the MolecuLight i:X™

Note: The MolecuLight i:XTM Imaging Device is available in Canada and the European Union. US FDA De Novo approval pending.

Methicillin Resistant Staphylococcus aureus (MRSA) infections are difficult to treat with standard types of antibiotics and are therefore more dangerous and costly to the healthcare system.

Clinical Synopsis: This non-healing venous leg ulcer patient presented with clinical signs and symptoms of inflammation that did not suggest bacterial presence during a routine wound care visit. However, the MolecuLight i:X Imaging Device detected the presence of red-fluorescing bacteria, prompting the clinician to swab the wound. Lab results confirmed the presence of MRSA.

Image taken in Standard Imaging ModeTM

Image taken in Fluorescence Imaging ModeTM
(presence of bacteria indicated by red color)